China market entry for U.S. medical device manufacturers
China market access
China medical device market entry
Enter China with accountable local representation.
BCAA Consulting helps U.S. medical device manufacturers establish the local presence China requires, execute NMPA registration work, and manage communication with regulators from first assessment through ongoing compliance.
CoverageChina
FocusMedical devices
CoordinationNMPA pathway
ApproachLocal presence + execution
Practical support for entering the China market.
Engage one workstream or coordinate the full China market-entry program. We start with the device, its current evidence, and the responsibilities shared across the manufacturer, local agent, testing bodies, and regulator.
01
China Agent through our partner network
Coordinate an accountable in-country agent through our China partner network, with a dependable channel for NMPA communications.
02
NMPA Registration
Pathway assessment, dossier planning, submission coordination, and lifecycle support for China registration.
03
Clinical Evaluation & Trial Support
China-specific clinical evaluation and, where required, clinical-trial planning and coordination.
04
Chinese Labeling & Translation
Controlled Chinese translation and labeling review aligned with the registration dossier.
05
Type Testing Coordination
Planning and coordination with qualified laboratories for product type testing and issue follow-through.
06
UDI Readiness
Applicability review, data preparation, and coordination for China UDI requirements.
07
08
09
10
A clear working rhythm.
Each China engagement is shaped around the device, existing evidence, and the regulatory work already completed.
Discovery
Understand the device, intended use, current approvals, and China-market objective.
Assessment
Assess the likely NMPA pathway, local-agent responsibilities, evidence gaps, and risk areas.
Workplan
Define scope, owners, milestones, fees, and communication cadence.
Execution
Coordinate the dossier, testing or clinical work, NMPA communication, and ongoing representation.
DecisionsPathway choices and open questions
EvidenceRequests, status, and review notes
CorrespondenceAuthority messages and next owners
Clear records keep cross-border work moving.
We organize decisions, evidence requests, and authority correspondence so the working team can see what is complete, what is open, and who owns the next step.
Transparent scoping before fees.
China registration costs vary by device class, testing requirements, clinical pathway, and dossier readiness. Rather than publish a misleading flat price, we show what drives each estimate.
China local agentAnnual term + defined legal and liaison scope
NMPA registrationDevice class, model family, and dossier readiness
Clinical and testing coordinationEvidence route, laboratory work, and study needs
Labeling, UDI, and lifecycle workScoped to the applicable China requirements
Common first questions.
Early clarity prevents avoidable delays. These answers are general; the right route depends on the device and manufacturer.
When does an overseas manufacturer need a China local agent?
An overseas NMPA applicant must appoint an in-country entity to carry out specified agent responsibilities. The exact arrangement depends on the product and registration route, but it is a legal operating role—not simply translation support.
Is NMPA registration only an administrative filing?
No. The pathway can involve product classification, technical documentation, type testing, clinical evaluation or trials, labeling, and regulator questions. The required work depends on the device.
Will every device need a clinical trial in China?
Not necessarily. The clinical route may involve an exemption, evaluation using existing evidence, or a local trial. It must be assessed against the current requirements and the device’s evidence base.
What should we prepare for a first consultation?
A product description, intended use, classification or approvals in other markets, available technical and clinical evidence, manufacturing details, and your target launch timing.
Bring us the device, your China-market objective, and the decision you need to make.
About BCAA Consulting
Local presence is the beginning. Execution is the advantage.
We help U.S. medical device manufacturers turn China-market requirements into an accountable local workstream.
The real barrier is not language. It is lawful local presence, regulatory execution, and experienced government communication.
Entering China requires more than translated documents. A manufacturer needs a legally recognized local presence, a workable NMPA strategy, evidence that fits the pathway, and disciplined ownership of every official question and response.
BCAA Consulting is structured around that operating reality. We connect U.S. decision-makers with the in-country representation and regulatory execution needed to move a China registration forward, while keeping ownership, records, and next steps clear.
Bilingual communication supports the work; it is not the work itself. Our value is making the pathway executable, maintaining continuity with authorities, and keeping the manufacturer accountable without leaving it alone.
One boutique practice, two market-entry directions.
BCAA Consulting is a boutique consultancy focused exclusively on medical-device access between the United States and China. Each market-facing site stays specific to the client’s destination, while our broader practice connects local representation, regulatory execution, and authority communication on both sides.
U.S. manufacturers → China
China market access
China local-agent support, NMPA registration coordination, clinical evaluation, type testing, labeling, and UDI readiness.
Chinese manufacturers → United States
U.S. market access
U.S. Agent representation, FDA establishment registration and device listing, 510(k) consulting, and official correspondence support.
How we intend to work.
A professional standard shaped for cross-border assignments.
Plain-language clarity
Explain the pathway, decision points, and open issues without hiding behind terminology.
Defined responsibility
Make clear what we own, what the manufacturer owns, and what depends on the authority.
Documented communication
Keep important requests, decisions, and next steps visible to the working team.
Tell us where your China market-entry work stands today.
Service framework
China representation, NMPA registration, and the work between them.
Choose a focused China-market service or combine related work into one coordinated engagement. Final scope depends on the device, classification, evidence, and NMPA pathway.
China market
China Agent through our partner network
Coordinate in-country representation through our China partner network, with clear responsibility for NMPA communication and regulatory follow-through.
Agent arrangement through qualified China partners
NMPA communication routing
Authority questions and escalation coordination
Official correspondence handling
China market
NMPA Registration
Structured planning and coordination for the China registration application.
Classification and pathway assessment
Dossier plan and document coordination
Submission and deficiency-response coordination
Registration change and renewal support
China market
Clinical Evaluation & Trial Support
Assessment and coordination of the clinical evidence route required for the device.
Clinical evaluation pathway assessment
Exemption and evidence applicability review
Clinical evidence gap assessment
Local trial planning and coordination when required
China market
Chinese Labeling & Translation
Controlled Chinese translation and labeling review aligned with registration.
Chinese labeling review
Controlled technical translation
Terminology and claims consistency
Labeling and dossier alignment
China market
Type Testing Coordination
Planning and coordination for product type testing within the China registration pathway.
Testing requirement and sample planning
Qualified laboratory coordination
Technical question follow-through
Report and dossier alignment
China market
UDI Readiness
Planning and coordination for applicable China UDI requirements.
UDI applicability review
Data and coding preparation
Submission coordination
Labeling consistency review
Selected engagements
Case studies are coming.
This section is reserved for approved engagement summaries. No client or project details will be published before review.
Case image reserved
Not sure which China pathway applies? Start with the device, intended use, and existing evidence.
The team
Cross-border partners focused on accountable market-entry execution.
Our partners bring together China-side industry relationships and U.S.-side market experience to support medical device companies entering either market.
Partner
Wang Yao
Wang Yao is a seasoned biopharmaceutical investor based in China and a graduate of Jinan University, with investments in multiple biopharmaceutical companies across China and expertise spanning both finance and industry. Long active in China's medical device sector, he has built extensive networks across the industry association and commercial ecosystem. At BCAA, Wang leads China-side strategic resources and industry partnerships — the scarcest link for US medical device companies entering China.
Partner
Frank Wang
Frank Wang came to the United States in 2015 and has lived here for over a decade, giving him a deep, firsthand understanding of both American and Chinese business cultures. He earned his bachelor's degree from New York University (Sports Management, minor in Nutrition) and a Master of Management Studies from Duke University's Fuqua School of Business — both with powerful alumni networks across the US. After graduation, he worked at a multinational trading company, where he developed deep expertise in taking products global. At BCAA, Frank leads US-side operations: he knows how the American market works, and he understands what Chinese companies need when entering it.
Future partner profiles The layout is ready to expand when China-based partners are confirmed for publication.
Reserved for a later phase
A cross-border engagement works best when roles are clear from day one.
Initial inquiry
Start with the device. We will help frame the China-market question.
Use this form to prepare a concise China market-entry inquiry, or reach us directly by phone at the number below.
